Accessibility settings

This paper is in the following e-collection/theme issue:

NIH funded proposals with peer-review reports (USA) (182) Methods and Feasibility Studies (724) Prevention and Health Promotion (2207) Cancer Survivorship (448) Patient Education for Cancer (318) Obesity and Nutrition as Public Health Problem (579) Nutrition, Physical Activity, Healthy Lifestyle for Cancer Patients and Survivors (252) Breast Cancer (402)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/86281, first published .
Yellow alarm clock on a white plate with fork and knife, symbolizing time-restricted eating

Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial

Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial

Authors of this article:

Katrina M Oselinsky1, 2, 3 Author Orcid Image ;   Emily B Hill2, 3, 4 Author Orcid Image ;   Danielle M Ostendorf1, 5 Author Orcid Image ;   Zhaoxing Pan2, 6 Author Orcid Image ;   Kristen Bing2 Author Orcid Image ;   Liza T Wayland2 Author Orcid Image ;   Chloe Simpson2 Author Orcid Image ;   Kevin C Clark2 Author Orcid Image ;   Anaeli Sandoval2 Author Orcid Image ;   Elizabeth A Thomas1, 2, 7, 8 Author Orcid Image ;   Ryan J Marker2, 3, 9 Author Orcid Image ;   Peter Kabos3, 10 Author Orcid Image ;   Paul S MacLean1, 2, 3 Author Orcid Image ;   Victoria A Catenacci1, 2, 3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Katrina M Oselinsky   1, 2, 3 , PhD ;   Emily B Hill   2, 3, 4 , PhD, RDN ;   Danielle M Ostendorf   1, 5 , PhD ;   Zhaoxing Pan   2, 6 , PhD ;   Kristen Bing   2 , RD ;   Liza T Wayland   2 , MA ;   Chloe Simpson   2 , BA ;   Kevin C Clark   2 , MS ;   Anaeli Sandoval   2 , BS ;   Elizabeth A Thomas   1, 2, 7, 8 , MD ;   Ryan J Marker   2, 3, 9 , PhD ;   Peter Kabos   3, 10 , MD ;   Paul S MacLean   1, 2, 3 , PhD ;   Victoria A Catenacci   1, 2, 3 , MD

1 Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

2 Anschutz Health and Wellness Center, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

3 University of Colorado Cancer Center, Aurora, CO, United States

4 Section of Nutrition, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

5 Department of Kinesiology, Recreation, and Sport Studies, University of Tennessee at Knoxville, Knoxville, TN, United States

6 Section of Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

7 Division of Endocrinology, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States

8 Research Service, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States

9 Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

10 Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States

Corresponding Author:

  • Katrina M Oselinsky, PhD
  • Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine
  • University of Colorado Anschutz Medical Campus
  • 12348 E Montview Blvd
  • Aurora, CO 80045
  • United States
  • Phone: 1 303-724-0624
  • Email: katrina.oselinsky@cuanschutz.edu